Evidence map›Paper›PMID 28374413›Full record

ArticleThe Journal of physiology2017

Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.

Nieves Gómez-Hurtado, Alejandro Domínguez-Rodríguez, Philippe Mateo, María Fernández-Velasco, Almudena Val-Blasco, Rafael Aizpún, Jessica Sabourin, Ana María Gómez, Jean-Pierre Benitah, Carmen Delgado

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Nieves Gómez-HurtadoDepartament of Pharmacology, School of Medicine, Complutense University, Madrid, Spain.ORCID 0000-0001-5338-7884
Alejandro Domínguez-RodríguezUMR-S 1180, Inserm, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Philippe MateoUMR-S 1180, Inserm, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
María Fernández-VelascoIdiPAZ Institute for Health Research/CIBER-CV, Madrid, Spain.
Almudena Val-BlascoIdiPAZ Institute for Health Research/CIBER-CV, Madrid, Spain.ORCID 0000-0001-7029-2895
Rafael AizpúnDepartament of Pharmacology, School of Medicine, Complutense University, Madrid, Spain.
Jessica SabourinUMR-S 1180, Inserm, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Ana María GómezUMR-S 1180, Inserm, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Jean-Pierre BenitahUMR-S 1180, Inserm, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.ORCID 0000-0002-9866-9081
Carmen DelgadoDepartament of Pharmacology, School of Medicine, Complutense University, Madrid, Spain.ORCID 0000-0002-0047-4674
Inserm · FRUniversidad Complutense de Madrid · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key pointsLeptin, is a 16 kDa pleiotropic peptide not only primarily secreted by adipocytes, but also produced by other tissues, including the heart. Controversy exists regarding the adverse and beneficial effects of leptin on the heart We analysed the effect of a non-hypertensive dose of leptin on cardiac function, [Ca ABSTRACT: Leptin, is a 16 kDa pleiotropic peptide not only primary secreted by adipocytes, but also produced by other tissues, including the heart. Evidence indicates that leptin may have either adverse or beneficial effects on the heart. To obtain further insights, in the present study, we analysed the effect of leptin treatment on cardiac function, [Ca

Indexed as

Action PotentialsAnimalsAortic Valve StenosisCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCardiotonic AgentsCells, CulturedKv Channel-Interacting ProteinsLeptinMaleMiceMice, Inbred C57BLMyocytes, CardiacRyanodine Receptor Calcium Release ChannelShal Potassium ChannelsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cardiotonic AgentsKcnip2 protein, mouseKv Channel-Interacting ProteinsLeptinRyanodine Receptor Calcium Release ChannelShal Potassium Channelsheart failureintracellular calciumleptin

Identifiers

PMID28374413
PMCPMC5491865
OpenAlexW2605198612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.